Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...
Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on ...
The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback